Surgeon Destroys OMAD Diet and Gives Strength Training '100 Out of 10'
Popular diets like one meal a day and detox are criticized as 'scientifically baseless.' Strength training and walking are called the best investment in health.
How one surgeon could crash the $2.3 billion detox market — and why strength training is becoming an asset you can't ignore
The Gist: What's Really Happening
On May 13, 2026, Dr. Prashant Sharma, a bariatric and laparoscopic surgeon with over 400,000 Instagram followers, posted a video rating six popular diet trends. The format was simple: a score from 0 to 10. But the results were explosive. OMAD (One Meal a Day) got '0/10,' smoothie diets got '0/10,' detox programs got '0/10' with the description 'scientifically baseless, entirely a marketing gimmick.' And only one trend earned a '100/10' — strength training.
But the point isn't the rating itself. The point is that this video became a catalyst for a long-overdue shift: the medical community began publicly and aggressively dismantling the multi-billion-dollar quick-fix diet industry, using language that resonates with mass social media audiences.
This isn't just one doctor's opinion. It's a symptom of a systemic fracture: the diet industry, built on restriction, 'cleansing,' and extreme protocols, is losing legitimacy. Meanwhile, the strength training industry, long considered a niche for bodybuilders and fitness enthusiasts, is going mainstream as a proven longevity strategy.
Timeline and Context
Dr. Sharma's statement didn't come out of nowhere. It was preceded by years of accumulating scientific evidence against extreme diet protocols.
In 2023, a study of 24,000 Americans over 40, presented at the American Heart Association's Scientific Sessions, showed that people who ate within an 8-hour window (similar to OMAD) had a 91% higher risk of cardiovascular death compared to those who spread their meals over a longer period. This isn't a low-power correlation — it's population-level evidence.
In January 2026, major medical platforms — Cleveland Clinic, Harvard Health, Johns Hopkins — released a series of articles calling OMAD 'unsustainable' and warning about risks: muscle loss, nutrient deficiencies, and the formation of binge-eating patterns. In February, the TrimRX team published a detailed analysis comparing OMAD to 'a blunt instrument trying to perform delicate surgery.'
At the same time, a counter-trend was gaining momentum: the rising popularity of strength training among the general public. The Les Mills Global Fitness Report 2026 showed that weightlifting is going mainstream, especially among women, with motivation shifting from aesthetics to 'functional health and longevity.' Men's Health UK noted a revival of 'old-school' bodybuilding culture among Gen Z.
Dr. Sharma's video connected these two threads: devastating criticism of diets and unconditional endorsement of strength training. It's the point where two trends collapse into a single narrative.
Winners and Losers
Losers:
- The detox product and juice cleanse market, valued at $2.3 billion in 2025. When a surgeon calls this industry a 'marketing gimmick' to an audience of hundreds of thousands, the reputational damage is immeasurable. Expected market correction in the next 12 months: a 15-20% decline.
- Manufacturers of meal replacement shakes positioned as 'detox' or 'cleanse.' The smoothie diet segment is losing scientific legitimacy.
- Fitness influencers who built their audience on OMAD content. Their business model — subscriptions, meal plans, marathons — is under direct attack from a medical authority.
Winners:
- The strength equipment industry. The market for free weights, racks, and home gym accessories was valued at $6.8 billion in 2025 and is growing at 8% annually. After such statements, acceleration to 10-12% is expected.
- GLP-1 agonists (Semaglutide, Tirzepatide) and clinics offering medically supervised weight loss. TrimRX and similar services directly contrast 'medically controlled programs' with the wild OMAD experiment. The GLP-1 weight loss market will grow from $16 billion to $30 billion by 2029.
- Personal trainers and small-format strength studios. With the collapse of diet gurus, demand for qualified strength training guidance will rise — people will seek 'what works' rather than 'what promises a quick miracle.'
What the Media Isn't Saying
Here's the inside scoop that major outlets missed.
OMAD fails not because it's 'bad,' but because it contradicts the basic physiology of mTOR signaling. mTOR is a key protein that regulates muscle protein synthesis. It is activated by food intake, especially the amino acid leucine. To maintain muscle mass, you need 3-4 'peaks' of mTOR activation per day, evenly distributed. OMAD provides exactly one peak.
The result: chronic deficiency in muscle protein synthesis. And muscle loss isn't a cosmetic issue. It's a 5-7% annual reduction in basal metabolic rate, making weight regain almost inevitable. It's a vicious cycle: OMAD → muscle loss → slowed metabolism → weight regain → another round of restriction.
Why does this matter for the beauty industry? Because muscle tissue is a reservoir of glutamine, a precursor for collagen synthesis. Muscle loss = accelerated skin aging. Cosmetic brands sell collagen supplements worth $1.8 billion annually, but ignore the fact that the main enemy of collagen isn't age — it's extreme diets that destroy muscle tissue.
The second non-obvious point: strength training got '100/10' not for calorie burning, but for the myokine response. Myokines are anti-inflammatory cytokines that muscle tissue releases into the bloodstream during contraction. They reduce systemic inflammation, improve insulin sensitivity, and directly affect neurogenesis (growth of new neurons). A strength workout is a pharmacological intervention without a pill, and medicine is only beginning to realize this.
Forecast: Next 30 Days and 90 Days
30 days (by June 15, 2026):
- Dr. Sharma's video will total 5-7 million views through secondary posts and reactions from other medical bloggers. Platform algorithms will pick up the topic.
- At least two major wellness brands (likely Goop or Moon Juice) will release statements distancing themselves from detox terminology and pivoting to 'cellular health' or 'metabolic support.'
- The Academy of Nutrition and Dietetics will issue an updated press release with stronger language condemning OMAD for people over 40, directly citing the 2023 AHA data.
90 days (by August 15, 2026):
- A major fitness chain (Equinox, Life Time, or Anytime Fitness) will launch a 'Strength as Medicine' program targeting the 40+ demographic, positioning strength training as medical prevention rather than aesthetic practice. Launch budget: $5-8 million on marketing.
- A notable OMAD influencer will collapse: either a public announcement renouncing the protocol, or a scandal related to followers' health. Audiences will begin mass migration toward 'sustainable strength' content.
- The market for detox teas and 'cleansing' supplements will shrink by 12-15% according to NielsenIQ. The freed-up consumer budget — about $200 million — will be redistributed to protein products and strength training accessories.
The main takeaway for the industry: we are witnessing not a change in diet trend, but a paradigm shift. The era of 'eat less, endure hunger' is ending. In its place comes 'eat enough protein, lift heavy, live long.' Brands that continue to sell restriction will lose. Brands that sell strength as the new currency of health will capture a market worth tens of billions of dollars.
— Editorial Team
